Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,385 | 5,227 | 5,417 | 7,230 | 9,821 |
| TOTAL | $134,221 | $6,828 | $6,447 | $7,887 | $10,494 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1 | 2 | 3 |
| Other Non-Current Assets | 123 | 145 | 219 | 301 | 383 |
| TOTAL | $123 | $145 | $220 | $303 | $386 |
| Total Assets | $134,344 | $6,973 | $6,667 | $8,190 | $10,880 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 384 | 211 | 314 | N/A | 79 |
| Accounts payable and accrued liabilities | 767 | 1,426 | 1,374 | 745 | 1,105 |
| Accrued Expenses | 3,485 | 1,841 | 2,258 | 1,974 | 1,962 |
| TOTAL | $4,636 | $3,478 | $3,970 | $2,777 | $3,236 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 328 | 283 | 77 | 82 | 152 |
| TOTAL | $328 | $283 | $77 | $82 | $152 |
| Total Liabilities | $4,964 | $3,761 | $4,047 | $2,859 | $3,388 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,885 | 149,003 | 9,119 | 4,796 | 4,397 |
| Common Shares | 1,594 | 91 | 48 | 43 | 27 |
| Retained earnings | -152,725 | -143,826 | -140,958 | -138,174 | -135,944 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $129,380 | $3,212 | $2,620 | $5,331 | $7,492 |
| Total Liabilities And Equity | $134,344 | $6,973 | $6,667 | $8,190 | $10,880 |